Facebook
X
LinkedIn
Forward
Addressing the Burden of PH-ILD: Early Recognition, Evidence-Based Management, & Care Coordination
Program / Course Description
This initiative is designed to close critical knowledge and competence gaps in pulmonary hypertension associated with interstitial lung disease (PH-ILD)—empowering clinicians to recognize disease earlier, screen proactively, and act decisively. By addressing disease progression, declining functional capacity, and quality-of-life impact, the program promotes coordinated multidisciplinary care and equips providers with the latest evidence-based strategies aligned to current clinical data and guidelines—ultimately improving outcomes in this high-risk population.
Target Audience
This educational activity is intended for pulmonologists and cardiologists.
Learning Objectives
Upon completion of this activity, learners should be able to:
- Summarize the increased clinical burden of PH-ILD and associated disease progression, including decreased functional capacity, impaired patient health-related quality of life, and increased mortality
- Identify approaches for improving the early diagnosis of PH-ILD, including proactive screening and symptom assessment and differentiation
- Evaluate the latest clinical data and practice guidelines to support evidence-based decision making in the treatment of PH-ILD
Copyright Information
Copyright © 2026 American Thoracic Society. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:
- The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
- Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without written permission from American Thoracic Society.
Commercial Support Acknowledgment
This activity is supported by an independent medical educational grant from United Therapeutics.
Course summary
- 1.00 AMA PRA Category 1 Credit(s)™
The American Thoracic Society designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation
Faculty
Steven D. Nathan, MD
Medical Director,
Advanced Lung Disease and Lung Transplant Program
Inova Fairfax Hospital
Falls Church, VA
Disclosures
Nathan is a consultant for Avalyn Pharma, United Therapeutics Corporation, Boehringer-Ingelheim, Daewoong Pharmaceutical Company and Merck. He also performs data and safety monitoring for Endeavor, AbbVie and Bristol-Myers Squibb. He is part of the End Point Review Committee for AstraZeneca and is an Advisory Board member for Gossamer.
Sandeep Sahay, MD, FCCP
Director, Pulmonary Hypertension Program, Co-Director,
Chronic Thromboembolic Pulmonary Hypertension Program
Houston Methodist Academic Medicine Associates - Transplant Pulmonology
Houston, Texas
Disclosures
Sahay participates in clinical trials for United Therapeutics Corporation. He is a consultant for Merck. He performs Data and Safety Monitoring for the NIH Clinical Center.
Planning Committee
Steven D. Nathan, MD
Medical Medical Director,
Advanced Lung Disease and Lung Transplant Program
Inova Fairfax Hospital
Falls Church, VA
Disclosures
Nathan is a consultant for Avalyn Pharma, United Therapeutics Corporation, Boehringer-Ingelheim, Daewoong Pharmaceutical Company and Merck. He also performs data and safety monitoring for Endeavor, AbbVie and Bristol-Myers Squibb. He is part of the End Point Review Committee for AstraZeneca and is an Advisory Board member for Gossamer.
Sandeep Sahay, MD, FCCP
Director, Pulmonary Hypertension Program, Co-Director,
Chronic Thromboembolic Pulmonary Hypertension Program
Houston Methodist Academic Medicine Associates - Transplant Pulmonology
Houston, Texas
Disclosures
Sahay participates in clinical trials for United Therapeutics Corporation. He is a consultant for Merck. He performs Data and Safety Monitoring for the NIH Clinical Center.
Michelle Kopp, PA-C
Inova Fairfax Hospital
Falls Church, VA
Disclosures
Nothing to disclose
Patricia Jackson, RN
Inova Fairfax Hospital
Falls Church, VA
Disclosures
Nothing to disclose
Margaret Das, PhD
Medical Writer
The France Foundation
Old Lyme, CT
Disclosures
Nothing to disclose
Patrick Harty, PhD
Medical Director
The France Foundation
Old Lyme, CT
Disclosures
Nothing to disclose
Amanda Noe
The France Foundation
Old Lyme, CT
Disclosures
Nothing to disclose
Emily Perkins
Project Manager
The France Foundation
Old Lyme, CT
Disclosures
Nothing to disclose
Heather Tarbox, MPH
Director of Education and Compliance
The France Foundation
Old Lyme, CT
Disclosures
Nothing to disclose
It is the policy of the ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. As an accredited CME provider, the ATS requires that its planners, reviewers and presenters comply with the ACCME Standards Integrity and Independence in Accredited Continuing Education. The ATS also requires specific disclosure of relationships with companies and organizations associated with tobacco or cannabis and prohibits or limits participation of faculty in official ATS activities, including CME, if any tobacco industry relationship or some types of cannabis industry relationships is present. The most recent policies regarding potential conflicts of interest as well as the mechanisms to mitigate or resolve such conflicts can be found here: COI Policy for Official ATS Activities (thoracic.org)
All relevant financial relationships listed have been mitigated
Accredited Provider
This physician activity is provided by the American Thoracic Society.
This nurse and PA activity is provided by The France Foundation.
American Thoracic Society - AMA Credits
Physicians
The American Thoracic Society (ATS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation
The American Thoracic Society designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The France Foundation - ANCC and AAPA Credits
In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Nurses
The France Foundation designates this activity for 1.0 contact hours.
Physician Assistants
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until 9/30/2026. PAs should only claim credit commensurate with the extent of their participation.
All other healthcare professionals completing this course will be issued a statement of participation.
Disclosure Policy
It is the policy of the ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. As an accredited CME provider, the ATS requires that its planners, reviewers and presenters comply with the ACCME Standards Integrity and Independence in Accredited Continuing Education. The ATS also requires specific disclosure of relationships with companies and organizations associated with tobacco or cannabis and prohibits or limits participation of faculty in official ATS activities, including CME, if any tobacco industry relationship or some types of cannabis industry relationships is present. The most recent policies regarding potential conflicts of interest as well as the mechanisms to mitigate or resolve such conflicts can be found here: COI Policy for Official ATS Activities (thoracic.org)
Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.
Disclosure of Unlabeled Use:
ATS and TFF require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. ATS and TFF do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
Available Credit
- 1.00 AMA PRA Category 1 Credit(s)™
The American Thoracic Society designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation
If you are requesting AMA credits or a certificate of participation, your certificate will be available for download.
CME Certificates of credit/attendance will be awarded based on the participant attending the activity, completing and submitting an evaluation and attesting to the credits earned. A CME certificate will be available upon successful completion.
All other healthcare professionals completing this course will be issued a certificate of participation.
The system keeps track of your progress. If you close the activity and resume it later, it will re-start where you left off.
Required Hardware/software
This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox and Safari browsers.
Additionally, this site and its activities are best viewed using the latest Operating System for your device.